Adagio Medical Holdings, Inc.ADGMNASDAQ
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank91
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Percentile
P91
Near historical high
vs 2Y Ago
199.6x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
PeriodValue
Q3 202540.74%
Q2 2025-46.13%
Q1 20257.08%
Q4 202438.45%
Q3 2024-13.86%
Q2 2024-17.41%
Q1 202495.55%
Q4 2023-59.85%
Q3 20230.20%
Q2 2023-8.11%
Q1 20237.72%
Q4 20220.00%